Neonatal Wireless Monitoring System for Intensive Care
Feasibility Study of a Neonatal Wireless Transmission System (NeWTS)
1 other identifier
interventional
20
1 country
1
Brief Summary
Babies who require intensive care need to have their heart rate, oxygen levels and temperature measured continuously using specially designed monitors. These monitors allow the clinical team to constantly assess the baby and see if they are becoming unwell. However, these monitors each have separate wires to connect them to the baby. Another important part of care in these babies is being able to allow parents to hold their babies, getting them out of their incubators to be cuddled. This is called Kangaroo care and has been shown to impact on long term health for both babies and parents. We have designed a system to free babies of the wires that tether them to the monitors. This system has been tested in adults and we now want to test them on the babies. There are two study parts with two different questions:
- 1.How good is the data? This will compare the new wireless system with the existing system. Babies will have both standard wired monitors and the new wireless monitor on at the same time so we can compare the data to see how good is the quality of the data collected on the new system.
- 2.What do parents and staff think about the wireless system during Kangaroo care? Babies who no longer need monitoring (but who previously had been monitored with the wired system), will have the wireless system attached and the parent will take their baby from the cot for Kangaroo Care. After the baby has been placed back in the cot, we will conduct interviews with the parent and the nurse to find out what they thought of the new system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2020
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedJanuary 12, 2021
January 1, 2021
1.4 years
January 12, 2020
January 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean (SD) difference in ECG waveform data
comparison of data between wired (standard care) and wireless system
Up to 24 hours of monitoring data per participant
Secondary Outcomes (2)
Impact on care: qualitative interviews with parents and staff
immediately post intervention
Impact on care: qualitative questionnaire with parents and staff
immediately post intervention
Study Arms (2)
Comparative assessment of data quality
OTHERQuantitative comparison between the current wired system and the new wireless system
Usability
OTHERQualitative assessment of the new wireless system
Interventions
Participants who currently have vital sign monitoring will, in addition, have the wireless system attached. We will then collect up to 24 hours of vital sign data from both systems, which will allow us to make direct comparisons between them.
Babies will be recruited who do not currently require vital sign monitoring. The wireless system will be attached to these babies by nurses who have been trained in its use. A parent will then be asked to perform Kangaroo Care for as long as they feel comfortable. After the baby is placed back in its cot, and the sensors have been removed, we will conduct (separate) interviews with the nurse and the parent on the neonatal intensive care unit (NICU).
Eligibility Criteria
You may qualify if:
- (i) Babies being cared for on the NICU at Addenbrooke's Hospital (ii) Written, informed parental consent
You may not qualify if:
- (i) Known to have an intolerance to silicone or silicone gel adhesives. (ii) Has a pacemaker, or other implanted electronic device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
kathryn beardsall
University of Cambridge
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This is a feasibility study but there are two arms and the babies, parents and staff will all be considered participants -it will be approximately 20 families recruited
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- University Lecturer, Consultant Neonatologist
Study Record Dates
First Submitted
January 12, 2020
First Posted
January 27, 2020
Study Start
March 1, 2020
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
January 12, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share